Aging Clinical and Experimental Research

, Volume 29, Issue 6, pp 1305–1311 | Cite as

“Brain-muscle loop” in the fragility of older persons: from pathophysiology to new organizing models

  • Fulvio Lauretani
  • Tiziana Meschi
  • Andrea Ticinesi
  • Marcello Maggio
Point of View

Abstract

Background

The imperative action of the geriatric medicine is to prevent disability in older persons. Many epidemiological studies have been conducted in the last decades for improving knowledge of the aging process and their interactions with age-related diseases, especially for the identification of the relationship between sarcopenia and loss of mobility. Factors influencing muscle integrity can be classified into six main physiologic subsystems, but the central nervous system certainly plays a crucial role for maintaining muscle integrity in older persons. Recent data show that the reduced muscle strength and not muscle mass could be considered the core of the fragility in predicting changes of gait velocity and mobility and conferring a higher risk of mortality in older persons. Sarcopenia and cognitive decline could, therefore, produce slow gait velocity in older persons, with devastating effect and consequences. Perhaps the most notorious corollary is falling, which is often caused by an underlying gait problem. Injuries caused by accidental falls range from relatively innocent bruises to major fractures or head trauma. Another important consequence is reduced mobility, which leads to loss of independence. This immobility is often compounded by a fear of falling, which further immobilises patients and affects their quality of life and physical performance.

Hypothesis

When we search the association between brain pathology and muscle function in older persons, we amazingly find that established composite measure of physical frailty is associated with brain pathology. Sarcopenia, which produces muscle dysfunction, slow gait velocity and cognitive decline, could share a strong bidirectional relationship, and this suggests the coexistence of both cognitive and motor dysfunctions in older persons to characterize a new syndrome characterized by slow gait and cognitive complaints, the motoric-cognitive risk syndrome (MRC).

Aim

In this review, we want to emphasize the relationship between memory complaints with muscle function integrating cognitive and physical evaluation, even with amyloid PET study, to identify older patients at high risk of cognitive and physical decline.

Keywords

Sarcopenia Cognitive impairment Older persons Motoric cognitive risk syndrome 

References

  1. 1.
    Ferrucci L, Bandinelli S, Benvenuti E et al (2009) Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 48:1618–1625CrossRefGoogle Scholar
  2. 2.
    Goodpaster BH, Carlson CL, Visser M et al (2001) Attenuation of skeletal muscle and strength in the elderly: the Health ABC Study. J Appl Physiol 90:2157–2165PubMedGoogle Scholar
  3. 3.
    Pahor M, Guralnik JM, Ambrosius WT et al (2014) Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. JAMA 311:2387–2396CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Clegg A, Young J, Iliffe S et al (2013) Frailty in elderly people. Lancet 381:752–762CrossRefPubMedGoogle Scholar
  5. 5.
    Rodríguez-Mañas L, Féart C, Mann G et al (2013) Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci 68:62–67CrossRefPubMedGoogle Scholar
  6. 6.
    Theou O, Brothers TD, Peña FG et al (2014) Identifying common characteristics of frailty across seven scales. J Am Geriatr Soc 62:901–906CrossRefPubMedGoogle Scholar
  7. 7.
    Ferrucci L, Guralnik JM, Studenski S Interventions on Frailty Working Group, et al (2004) Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report. J Am Geriatr Soc 52:625–634CrossRefPubMedGoogle Scholar
  8. 8.
    Lauretani F, Russo CR, Bandinelli S et al (2003) Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95:1851–1860CrossRefPubMedGoogle Scholar
  9. 9.
    Studenski SA, Peters KW, Alley DE et al (2014) The FNIH sarcopenia project rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci 69:547–558CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    McLean RR, Shardell MD, Alley DE et al (2014) Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci 69:576–583CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Lauretani F, Bautmans I, De Vita F et al (2014) Identification and treatment of older persons with sarcopenia. Aging Male 17:199–204CrossRefPubMedGoogle Scholar
  12. 12.
    Montero-Odasso M, Verghese J, Beauchet O et al (2012) Gait and cognition: a complementary approach to understanding brain function and the risk of falling. J Am Geriatr Soc 60:2127–2136CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Snijders AH, van de Warrenburg BP, Giladi N et al (2007) Neurological gait disorders in elderly people: clinical approach and classification. Lancet Neurol 6:63–74CrossRefPubMedGoogle Scholar
  14. 14.
    Bloem BR, Haan J, Lagaay AM et al (1992) Investigation of gait in elderly subjects over 88 years of age. J Geriatr Psychiatry Neurol 5:78–84PubMedGoogle Scholar
  15. 15.
    Deshpande N, Metter EJ, Lauretani F et al (2008) Activity restriction induced by fear of falling and objective and subjective measures of physical function: a prospective cohort study. J Am Geriatr Soc 56:615–620CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Studenski S, Perera S, Patel K et al (2011) Gait speed and survival in older adults. JAMA 305:50–58CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Verghese J, Ayers E, Barzilai N et al (2014) Motoric cognitive risk syndrome: multicenter incidence study. Neurology 83:2278–2284CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Verghese J, Annweiler C, Ayers E et al (2014) Motoric cognitive risk syndrome: multicountry prevalence and dementia risk. Neurology 83:718–726CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Verghese J, Lipton RB, Hal CB et al (2002) Abnormality of gait as a predictor of non-Alzheimer’s dementia. N Engl J Med 347:1761–1768CrossRefPubMedGoogle Scholar
  20. 20.
    Wilson RS, Schneider JA, Beckett LA et al (2002) Progression of gait disorder and rigidity and risk of death in older persons. Neurology 58:1815–1819CrossRefPubMedGoogle Scholar
  21. 21.
    Newman AB, Gottdiener JS, McBurnie MA et al (2001) Associations of subclinical cardiovascular disease with frailty. J Gerontol A Biol Sci Med Sci 56:M158–M166CrossRefPubMedGoogle Scholar
  22. 22.
    Newman AB, Haggerty CL, Kritchevsky SB et al (2003) Walking performance and cardiovascular response: associations with age and morbidity: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 58:715–720CrossRefPubMedGoogle Scholar
  23. 23.
    Ferrucci L, Bandinelli S, Cavazzini C et al (2004) Neurological examination findings to predict limitations in mobility and falls in older persons without a history of neurological disease. Am J Med 116:807–815CrossRefPubMedGoogle Scholar
  24. 24.
    Inzitari M, Pozzi C, Ferrucci L et al (2008) Subtle neurological abnormalities as risk factors for cognitive and functional decline, cerebrovascular events, and mortality in older community-dwelling adults. Arch Intern Med 168:1270–1276CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Buchman AS, Yu L, Wilson RS et al (2013) Association of brain pathology with the progression of frailty in older adults. Neurology 80:2055–2061CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Buchman AS, Yu L, Wilson RS et al (2014) Brain pathology contributes to simultaneous change in physical frailty and cognition in old age. J Gerontol A Biol Sci Med Sci 69:1536–1544CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Del Campo N, Payoux P, Djilali A, DSA Study Group et al (2016) Relationship of regional brain β-amyloid to gait speed. Neurology 86:36–43CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Kaup AR, Nettiksimmons J, LeBlanc ES et al (2015) Memory complaints and risk of cognitive impairment after nearly 2 decades among older women. Neurology 85:1852–1858CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Snitz BE, Lopez OL, McDade E et al (2015) Amyloid-β imaging in older adults presenting to a memory clinic with subjective cognitive decline: a pilot study. J Alzheimers Dis 48:S151–S159CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Buchman AS, Wilson RS, Shulman JM et al (2016) Parkinsonism in older adults and its association with adverse health outcomes and neuropathology. J Gerontol A Biol Sci Med Sci 71:549–556CrossRefPubMedGoogle Scholar
  31. 31.
    Berra K, Rippe J, Manson JE (2015) Making physical activity counseling a priority in clinical practice: the time for action is now. JAMA 10:1–2Google Scholar
  32. 32.
    Fleischman DA, Yang J, Arfanakis K et al (2015) Physical activity, motor function, and white matter hyperintensity burden in healthy older adults. Neurology 84:1294–1300CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Gow AJ, Bastin ME, Muñoz Maniega S et al (2012) Neuroprotective lifestyles and the aging brain: activity, atrophy, and white matter integrity. Neurology 79:1802–1808CrossRefPubMedGoogle Scholar
  34. 34.
    Colcombe SJ, Erickson KI, Scalf PE et al (2006) Aerobic exercise training increases brain volume in aging humans. J Gerontol A Biol Sci Med Sci 61:1166–1170CrossRefPubMedGoogle Scholar
  35. 35.
    Young J, Angevaren M, Rusted J et al (2015) Aerobic exercise to improve cognitive function in older people without known cognitive impairment. Cochrane Database Syst Rev 4:CD005381Google Scholar
  36. 36.
    Agudelo LZ, Femenía T, Orhan F et al (2014) Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell 159:33–45CrossRefPubMedGoogle Scholar
  37. 37.
    Beeri MS, Sonnen J (2016) Brain BDNF expression as a biomarker for cognitive reserve against Alzheimer disease progression. Neurology 86:702–703CrossRefPubMedGoogle Scholar
  38. 38.
    Brown BM, Peiffer JJ, Martins RN (2013) Multiple effects of physical activity on molecular and cognitive signs of brain aging: can exercise slow neurodegeneration and delay Alzheimer’s disease? Mol Psychiatry 18:864–874CrossRefPubMedGoogle Scholar
  39. 39.
    Currie J, Ramsbottom R, Ludlow H et al (2009) Cardio-respiratory fitness, habitual physical activity and serum brain derived neurotrophic factor (BDNF) in men and women. Neurosci Lett 451:152–155CrossRefPubMedGoogle Scholar
  40. 40.
    Coelho FG, Vital TM, Stein AM et al (2014) Acute aerobic exercise increases brain-derived neurotrophic factor levels in elderly with Alzheimer’s disease. J Alzheimers Dis 39:401–408PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Fulvio Lauretani
    • 1
    • 3
  • Tiziana Meschi
    • 1
  • Andrea Ticinesi
    • 1
  • Marcello Maggio
    • 2
    • 3
  1. 1.Internal Medicine and Critical Subacute Care Unit, Cognitive and Motoric Ambulatory, Geriatric-Rehabilitation DepartmentParma University-HospitalParmaItaly
  2. 2.Geriatric Clinic, Geriatric-Rehabilitation DepartmentUniversity HospitalParmaItaly
  3. 3.Department of Clinical and Experimental MedicineUniversity of ParmaParmaItaly

Personalised recommendations